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Background
Both AIDS defining malignancies and non AIDS defining
malignancies occurring in HIV infected persons are poorly
documented in Nigeria. Our hospital is a reference centre
located in one of the South-South states, which has a HIV
sero prevalence of 8% [1] (http://data.unaids.org/pub/
Report/2010/nigeria_2010_country_progress_report_en.
pdf), with a low antiretroviral coverage [1].
Material and methods
A five year retrospective study was carried out to review
the frequency of diagnosis of three tumours classified as
AIDS defining malignancies (Kaposi sarcoma, non
Hodgkin lymphoma, cervical cancer) and one non AIDS
defining malignancy (squamous cell carcinoma of the
conjunctiva), also commonly diagnosed in these patients.
Records of the patients which are histologically con-
firmed and diagnosed between 1
st January 2005 and 31
st
January 2009 were sorted out and their retroviral status
classified.
Results
A total of 4123 histologically confirmed biopsies were
received, 852 (21%) were cancers, 24 (2.8%) were Kaposi
sarcoma (KS), 8 (33%) KS occurred in females, range
21-60 years (y), 16 (67%) in males, range 19-60 y and 17
(71%) of KS were AIDS associated, 6 (35%) females and
11 (65%) males. Thirty five 35 (4.1%) of cancers were
Non Hodgkin lymphomas including Burkitt’sl y m p h o -
mas, 8 (23%) in females, range 6-60 y and males 27
(77%), range 6-71 y. Two 2 (5.7%) were AIDS associated
2 (100%) were males on long standing antiretroviral
treatment. Cervical cancers accounted for 84 (9.9%) all
cancers and 14 (17%) occurred in HIV positive patients
age range. Conjunctival squamous cell carcinomas were
13 (1.5%) of all cancers, 6 (46%) females 7 (54%) males.
Two 2 (15%) occurred in HIV positive patients.
Conclusion
AIDS associated malignancies appear to be very common
in this environment and perhaps non AIDS associated
malignancies may be on the increase. Under-reporting
and lack of capacity may account for the fewer numbers
reported in this environment.
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